Novo Nordisk A/s Class B · OMXCOP:NOVO_B
Novo Nordisk A/s Class B — Fact Sheet (November 2022)
2 slides from Novo Nordisk A/s Class B's fact sheet, November 2022
Slide 1: What is obesity? The burden of obesity
What is Prevention Accelerator Worldwide, 650 million obesity? adults live with 975 million obesity 1 adults will live with obesity in 2030 1 124 million Be a part of the change children living with obesity Predicted globally1 to rise to 250 million by 20302 Obesity is commonly measured using body m
Slide 2: Prevention Accelerator
Obesity is a multifactorial disease, but there remains an underlying Prevention Accelerator societal belief that obesity is a result of lack of willpower, which can For more information on obesity and Novo Nordisk’s lead to people with obesity being subjected to blame and stigma in commitment to dri